Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models

Background: To investigate the prognostic value of circulating plasma cells (CPC) and establish novel nomograms to predict individual progression-free survival (PFS) as well as overall survival (OS) of patients with newly diagnosed multiple myeloma (NDMM). Methods: One hundred ninetyone NDMM patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Qianwen, Cai, Li, Zhang, Yuyang, Chen, Lei, Hu, Yu, Sun, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973368/
https://www.ncbi.nlm.nih.gov/pubmed/33747963
http://dx.doi.org/10.3389/fonc.2021.639528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973368/
https://www.ncbi.nlm.nih.gov/pubmed/33747963
http://dx.doi.org/10.3389/fonc.2021.639528

Ejemplares similares